Moderna
(NASDAQ) MRNA
Moderna Financials at a Glance
Market Cap
$20.06B
Revenue (TTM)
$1.94B
Net Income (TTM)
$2.82B
EPS (TTM)
$-7.26
P/E Ratio
-7.00
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$50.08
Volume
7,548,936.569
Open
$51.64
Price
$50.08
Volume
7,548,936.569
Open
$51.64
Previous Close
$50.03
Daily Range
$49.58 - $52.78
52-Week Range
$22.28 - $59.55
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$50.08
Volume
7,548,936.569
Open
$51.64
Previous Close
$50.03
Daily Range
$49.58 - $52.78
52-Week Range
$22.28 - $59.55
MRNA News
MRNA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Moderna
Industry
Biotechnology
Sector
Health CareEmployees
4,700
CEO
Stéphane Bancel, MBA
Website
www.modernatx.comHeadquarters
Cambridge, MA 02142, US
MRNA Financials
Key Financial Metrics (TTM)
Gross Margin
14%
Operating Margin
-2%
Net Income Margin
-1%
Return on Equity
-29%
Return on Capital
-30%
Return on Assets
-23%
Earnings Yield
-14.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.06B
Shares Outstanding
394.94M
Volume
7.55M
Short Interest
0.00%
Avg. Volume
11.18M
Financials (TTM)
Gross Profit
$1.08B
Operating Income
$3.07B
EBITDA
$2.55B
Operating Cash Flow
$1.87B
Capital Expenditure
$192.00M
Free Cash Flow
$2.06B
Cash & ST Invst.
$5.80B
Total Debt
$1.92B
Moderna Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$678.00M
-29.1%
Gross Profit
$226.00M
+4.1%
Gross Margin
33.33%
N/A
Market Cap
$20.06B
N/A
Market Cap/Employee
$3.46M
N/A
Employees
5,800
N/A
Net Income
$826.00M
+26.3%
EBITDA
$732.00M
+34.5%
Quarterly Fundamentals
Net Cash
$3.88B
-38.1%
Accounts Receivable
$184.00M
-68.9%
Inventory
$153.00M
+30.8%
Long Term Debt
$1.92B
+169.9%
Short Term Debt
$0.00
-100.0%
Return on Assets
-22.87%
N/A
Return on Invested Capital
-29.70%
N/A
Free Cash Flow
$912.00M
+201.0%
Operating Cash Flow
$951.00M
+15.3%